Back to discover
Drug

Amylose

Research stage
Emerging research
RxNorm752UNII7TDQ74Y18L
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Multiomics of a rice population identifies genes and genomic regions that bestow low glycemic index and high protein content.

Research2024-08-27Proceedings of the National Academy of Sciences of the United States of America

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Amylose
RxNorm CUI
752
UNII
7TDQ74Y18L

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Multiomics of a rice population identifies genes and genomic regions that bestow low glycemic index and high protein content.

Proceedings of the National Academy of Sciences of the United States of America · 2024 · 12 cites
Recent papers

Multiomics of a rice population identifies genes and genomic regions that bestow low glycemic index and high protein content.

Proceedings of the National Academy of Sciences of the United States of America · 2024 · 12 cites
Major research themes4
Amylose1Glycemic Index1Oryza1Quantitative Trait Loci1
Journals, researchers & institutions
Top journals
  • Proceedings of the National Academy of Sciences of the United States of America1
Leading researchers
  • Alseekh S1
  • Badoni S1
  • Buenafe RJQ1
  • Fernie AR1
  • Khush GS1
  • Kim SR1
  • Kohli A1
  • Kor S1
Leading institutions
free-text, unnormalised
  • Center of Plant Systems Biology1
  • International Rice Research Institute1
  • International Rice Research Institute South Asia Regional Centre1
  • Max-Planck-Institute of Molecular Plant Physiology1
  • University of California1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature